Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$103.80 +0.8%	$103.46	$71.88 ▼ $107.53	$152.32B	0.68	6.67 million shs	7.22 million shs
CSQ Calamos Strategic Total Return Fund	$18.34 +0.3%	$17.43	$13.11 ▼ $18.55	N/A	N/A	204,325 shs	176,602 shs
ISRG Intuitive Surgical	$526.05 -0.4%	$538.20	$413.82 ▼ $616.00	$189.29B	1.64	1.67 million shs	1.42 million shs
SYK Stryker	$394.67 +0.7%	$384.57	$314.93 ▼ $406.19	$149.64B	0.91	1.35 million shs	1.17 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+0.81%	-0.48%	+4.60%	+10.82%	+34.61%
CSQ Calamos Strategic Total Return Fund	+0.27%	-0.54%	+3.79%	+22.35%	+4.74%
ISRG Intuitive Surgical	-0.39%	-3.25%	-0.67%	+6.57%	+18.28%
SYK Stryker	+0.67%	+0.68%	+2.46%	+12.76%	+16.99%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSX Boston Scientific	4.7253 of 5 stars	3.6	3.0	0.0	4.2	3.7	2.5	1.3
CSQ Calamos Strategic Total Return Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	4.6964 of 5 stars	3.4	3.0	0.0	4.0	3.0	2.5	1.9
SYK Stryker	4.6431 of 5 stars	2.4	3.0	3.3	4.2	3.0	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	3.13	Buy	$116.09	11.84% Upside
CSQ Calamos Strategic Total Return Fund	0.00	N/A	N/A	N/A
ISRG Intuitive Surgical	2.70	Moderate Buy	$592.59	12.65% Upside
SYK Stryker	2.79	Moderate Buy	$428.55	8.58% Upside

Current Analyst Ratings Breakdown

Latest SYK, CSQ, ISRG, and BSX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	ISRG Intuitive Surgical	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$470.00 ➝ $550.00
7/8/2025	SYK Stryker	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$390.00 ➝ $415.00
6/16/2025	BSX Boston Scientific	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	BSX Boston Scientific	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$118.00
6/9/2025	ISRG Intuitive Surgical	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$515.00 ➝ $440.00
6/5/2025	ISRG Intuitive Surgical	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
5/28/2025	BSX Boston Scientific	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$115.00
5/22/2025	BSX Boston Scientific	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$119.00 ➝ $125.00
5/22/2025	ISRG Intuitive Surgical	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$590.00 ➝ $650.00
5/22/2025	SYK Stryker	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$443.00 ➝ $455.00
5/16/2025	BSX Boston Scientific	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$120.00 ➝ $125.00

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$16.75B	9.17	$3.68 per share	28.20	$14.93 per share	6.95
CSQ Calamos Strategic Total Return Fund	$280.21M	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	$8.35B	22.57	$7.96 per share	66.11	$46.41 per share	11.33
SYK Stryker	$22.60B	6.67	$15.19 per share	25.99	$54.13 per share	7.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$1.85B	$1.37	75.76	32.13	2.68	11.58%	18.67%	10.38%	7/23/2025 (Estimated)
CSQ Calamos Strategic Total Return Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	$2.32B	$6.82	77.13	68.94	5.60	28.41%	14.43%	12.81%	7/22/2025 (Estimated)
SYK Stryker	$2.99B	$7.40	53.33	26.61	2.96	12.31%	23.74%	11.25%	7/31/2025 (Estimated)

Latest SYK, CSQ, ISRG, and BSX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/31/2025	Q2 2025	SYK Stryker	$3.06	N/A	N/A	N/A	$5.92 billion	N/A
7/23/2025	Q2 2025	BSX Boston Scientific	$0.72	N/A	N/A	N/A	$4.89 billion	N/A
7/22/2025	Q2 2025	ISRG Intuitive Surgical	$1.92	N/A	N/A	N/A	$2.35 billion	N/A
5/1/2025	Q1 2025	SYK Stryker	$2.73	$2.84	+$0.11	$1.69	$5.68 billion	$5.87 billion
4/23/2025	Q1 2025	BSX Boston Scientific	$0.67	$0.75	+$0.08	$0.45	$4.57 billion	$4.66 billion
4/22/2025	Q1 2025	ISRG Intuitive Surgical	$1.71	$1.81	+$0.10	$1.92	$2.19 billion	$2.25 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
CSQ Calamos Strategic Total Return Fund	$1.23	6.71%	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
SYK Stryker	$3.36	0.85%	N/A	45.41%	32 Years

Latest SYK, CSQ, ISRG, and BSX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/8/2025	SYK Stryker	quarterly	$0.84	0.88%	6/30/2025	6/30/2025	7/31/2025
7/1/2025	CSQ Calamos Strategic Total Return Fund	Monthly	$0.1025	6.67%	7/14/2025	7/14/2025	7/21/2025
6/2/2025	CSQ Calamos Strategic Total Return Fund	monthly	$0.1025	7%	6/12/2025	6/12/2025	6/20/2025
5/1/2025	CSQ Calamos Strategic Total Return Fund	monthly	$0.1025	7.5%	5/13/2025	5/13/2025	5/20/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.47	1.45	0.88
CSQ Calamos Strategic Total Return Fund	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	4.98	3.97
SYK Stryker	0.69	1.64	1.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
CSQ Calamos Strategic Total Return Fund	N/A
ISRG Intuitive Surgical	83.64%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.50%
CSQ Calamos Strategic Total Return Fund	N/A
ISRG Intuitive Surgical	0.70%
SYK Stryker	5.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	53,000	1.48 billion	1.47 billion	Optionable
CSQ Calamos Strategic Total Return Fund	N/A	N/A	N/A	Not Optionable
ISRG Intuitive Surgical	15,638	358.42 million	355.91 million	Optionable
SYK Stryker	53,000	381.69 million	359.17 million	Optionable

SYK, CSQ, ISRG, and BSX Headlines

Recent News About These Companies

North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies

1 hour ago | globenewswire.com

Brown Advisory Inc. Has $17.53 Million Holdings in Stryker Corporation (NYSE:SYK)

1 hour ago | marketbeat.com

Evercore ISI Increases Stryker (NYSE:SYK) Price Target to $415.00

4 hours ago | americanbankingnews.com

8,034 Shares in Stryker Corporation (NYSE:SYK) Purchased by Financial Gravity Asset Management Inc.

July 10 at 9:09 AM | marketbeat.com

Allworth Financial LP Purchases 744 Shares of Stryker Corporation (NYSE:SYK)

July 10 at 8:51 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Bought by Parr Mcknight Wealth Management Group LLC

July 10 at 8:37 AM | marketbeat.com

What to Expect From Stryker's Next Quarterly Earnings Report

July 10 at 8:21 AM | finance.yahoo.com

Trek Financial LLC Has $228,000 Stake in Stryker Corporation (NYSE:SYK)

July 10 at 6:13 AM | marketbeat.com

Penserra Capital Management LLC Buys 1,132 Shares of Stryker Corporation (NYSE:SYK)

July 10 at 4:46 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Sold by Bridges Investment Management Inc.

July 9 at 10:29 AM | marketbeat.com

Nisa Investment Advisors LLC Sells 22,171 Shares of Stryker Corporation (NYSE:SYK)

July 9 at 10:01 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Purchased by Banque Pictet & Cie SA

July 9 at 9:43 AM | marketbeat.com

Lbp Am Sa Grows Stock Position in Stryker Corporation (NYSE:SYK)

July 9 at 9:28 AM | marketbeat.com

Rehmann Capital Advisory Group Has $22.49 Million Stake in Stryker Corporation (NYSE:SYK)

July 9 at 8:59 AM | marketbeat.com

Arcadia Investment Management Corp MI Lowers Stock Position in Stryker Corporation (NYSE:SYK)

July 9 at 8:27 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Stock Holdings Decreased by Greenleaf Trust

July 9 at 8:06 AM | marketbeat.com

Flossbach Von Storch SE Lowers Holdings in Stryker Corporation (NYSE:SYK)

July 9 at 7:59 AM | marketbeat.com

M&T Bank Corp Acquires 1,342 Shares of Stryker Corporation (NYSE:SYK)

July 9 at 6:46 AM | marketbeat.com

Ninety One UK Ltd Reduces Stock Position in Stryker Corporation (NYSE:SYK)

July 9 at 6:17 AM | marketbeat.com

Envestnet Asset Management Inc. Raises Position in Stryker Corporation (NYSE:SYK)

July 9 at 5:32 AM | marketbeat.com

Border Patrol releases video of Stryker battalion arriving in Laredo

July 8 at 9:55 PM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
By Leo Miller | June 19, 2025
View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

SYK, CSQ, ISRG, and BSX Company Descriptions

Boston Scientific NYSE:BSX

$103.80 +0.84 (+0.81%)

Closing price 07/10/2025 03:59 PM Eastern

Extended Trading

$103.74 -0.05 (-0.05%)

As of 05:29 AM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Calamos Strategic Total Return Fund NASDAQ:CSQ

$18.34 +0.05 (+0.27%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$18.32 -0.02 (-0.11%)

As of 07/10/2025 04:10 PM Eastern

Calamos Strategic Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The fund is managed by Calamos Advisors LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in common and preferred stocks of companies across all market capitalizations, convertible securities, and high yield corporate bonds with an average credit rating of BB as rated by S&P. The fund employs both fundamental and quantitative analysis with a combination of bottom-up and top-down security picking approaches to create its portfolio. Calamos Strategic Total Return Fund was formed on December 31, 2003 and is domiciled in the United States.

Intuitive Surgical NASDAQ:ISRG

$526.05 -2.08 (-0.39%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$524.50 -1.55 (-0.29%)

As of 05:30 AM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stryker NYSE:SYK

$394.67 +2.62 (+0.67%)

Closing price 07/10/2025 03:59 PM Eastern

Extended Trading

$395.56 +0.89 (+0.23%)

As of 05:21 AM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time